Evaluation of effect of acarbose consumption on weight losing in non-diabetic overweight or obese patients in Kerman

This 2013 double-blind, randomized controlled trial assessed the efficacy of acarbose (100 mg three times daily) combined with a low-calorie diet and exercise over 20 weeks in 66 non-diabetic overweight or obese adults (BMI 25–35 kg/m²) in Kerman, Iran. Both treatment and placebo groups followed the same diet and exercise